Shanghai Serum Bio-Technology Co. Ltd. A

SHG:688163 China Biotechnology

Market Cap

$354.43 Million

CN¥2.60 Billion CNY

Market Cap Rank

#16638 Global

#4397 in China

Share Price

CN¥24.03

Change (1 day)

-1.07%

52-Week Range

CN¥15.17 - CN¥27.37

All Time High

CN¥50.70

Shanghai Serum Bio-Technology Co. Ltd. A - Asset Resilience Ratio

Latest as of June 2025: 53.88%

Shanghai Serum Bio-Technology Co. Ltd. A (688163) has an Asset Resilience Ratio of 53.88% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥611.87 Million

Cash + Short-term Investments

Total Assets

CN¥1.14 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Shanghai Serum Bio-Technology Co. Ltd. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Serum Bio-Technology Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥611.87 Million	53.88%
Total Liquid Assets	CN¥611.87 Million	53.88%

Asset Resilience Insights

Very High Liquidity: Shanghai Serum Bio-Technology Co. Ltd. A maintains exceptional liquid asset reserves at 53.88% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.